About Delineate
Delineate is building AI agents to design better clinical trials faster.
This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential.
We process existing clinical trial research into specialized datasets saving scientists months of effort.
Delineate is working with two of the largest pharmaceutical companies. With one of our customers, we are helping them get to the next phase of trials faster by creating the largest dataset on a drug class ever constructed.
Company details
Funding
Total raised
$1.5M
Last stage
Seed
Investors
Founders
Emily Nieves
Former MIT PhD Candidate in Biological Engineering; previously worked at Pfizer and AstraZeneca focusing on AI applied to modeling and simulation for drug development optimization.
LinkedIn
Jawad Iqbal
Co-Founder and CTO of Delineate. Masters thesis in Robotics/AI with 2 research publications. Former technical project manager for high impact digital transformation projects within Skunkworks (Advanced Development) division at Lockheed Martin.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.